TCTMD

IV Iron in HF: Mixed Data Haven’t Dashed Interest

Pieter Martens, MD, PhD (Hospital Oost-Limburg, Genk, Belgium), who made the “pro” case on behalf of IV iron, pointed out ...
Business Wire

American Regent Expands Promotional Campaign for Iron Deficiency Anemia Drug Injectafer ® (Ferric Carboxymaltose Injection)

First and only high-dose intravenous iron for iron deficiency anemia of various etiologies SHIRLEY, N.Y.--(BUSINESS WIRE)--American Regent, Inc., a subsidiary of Luitpold Pharmaceuticals, Inc. (a ...
Healio

Risk for anaphylaxis from IV iron overall ‘very low,’ but varies between formulations

Please provide your email address to receive an email when new articles are posted on . The risk for anaphylaxis from IV iron formulations appeared low, although it varied depending on the type of ...
Healio

IV iron most cost-effective for iron deficiency anemia, heavy menstrual bleeding

Please provide your email address to receive an email when new articles are posted on . IV iron is the most cost-effective option for women with iron deficiency anemia and heavy menstrual bleeding.
TCTMD

FDA Grants First HF Indication for IV Iron to Ferric Carboxymaltose

Ferric carboxymaltose has become the first form of intravenous iron replacement to earn a US Food and Drug Administration indication for heart failure, the manufacturer announced today. Injectafer ...
The American Journal of Managed Care

Factoring in Safety Considerations With IV Iron Products

Panelists discuss how black box warnings on IV iron products, particularly regarding hypersensitivity reactions, influence their risk assessment, patient selection, monitoring protocols, and facility ...
Yahoo Finance

Intravenous Iron Drugs Market Projected to Hit $8.71 Billion by 2035 – SNS Insider

Austin, United States, March 26, 2026 (GLOBE NEWSWIRE)-- Intravenous Iron Drugs Market Size & Growth Analysis: According to SNS Insider, The global Intravenous Iron Drugs Market was valued at USD 3.57 ...